Indications and uses
relieves heartburn associated with acid indigestion and sour stomach
relieves heartburn associated with acid indigestion and sour stomach
• adults and children 12 years and over: • do not swallow tablet whole: chew completely • to relieve symptoms, chew 1 tablet before swallowing • do not use more than 2 chewable tablets in 24 hours • children under 12 years: ask a doctor
• each tablet contains: calcium 320 mg; magnesium 70 mg • Phenylketonurics: Contains phenylalanine 2.2 mg per tablet • read the directions and warnings before use • read the bottle label. It contains important information. • store at 20-25°C (68-77°F) • protect from moisture
Famotidine 10 mg
Calcium carbonate 800 mg
Magnesium hydroxide 165 mg
Acid reducer
Antacid
relieves heartburn associated with acid indigestion and sour stomach
Allergy alert: Do not use if you are allergic to famotidine or other acid reducers
presently taking a prescription drug. Antacids may interact with certain prescription drugs.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
anhydrous lactose, artificial berry flavor, aspartame, D&C red no. 7 calcium lake, dextrates, FD&C blue no. 1 aluminum lake, FD&C red no. 40 aluminum lake, glyceryl monostearate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyacrylate dispersion, polysorbate 80, povidone, pregelatinized starch, sodium starch glycolate, talc
1-800-719-9260
COMPARE TO THE ACTIVE INGREDIENTS OF PEPCID COMPLETE®
Dual Action
Acid Controller Complete
Famotidine 10 mg, Calcium Carbonate 800 mg, Magnesium Hydroxide 165 mg Tablets
Acid Reducer Plus Antacid
Just One Tablet! Relieves Heartburn Due to Acid Indigestion
ACTUAL SIZE
BERRY FLAVOR


| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 1 | |
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | 1 | |
| MAGNESIUM HYDROXIDE | ACTIVE INGREDIENT | NBZ3QY004S | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | 1 | |
| HYDROXIDE ION | ACTIVE MOIETY | 9159UV381P | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | 1 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| DEXTRATES | INACTIVE INGREDIENT | G263MI44RU | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55319-321 | 55319-321-63 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FAMOTIDINE | 5QZO15J2Z8 | ACTIB |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | ACTIB |
| CALCIUM CARBONATE | H0G9379FGK | ACTIB |
| ASPARTAME | Z0H242BBR1 | IACT |
| DEXTRATES | G263MI44RU | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | IACT |
| TALC | 7SEV7J4R1U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TALC | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 214 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | GRANULE, FOR SUSPENSION / ORAL | 240 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / ORAL | 907 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | CAPSULE / ORAL | 2490 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| DEXTRATES | DEXTRATES | G263MI44RU | LOZENGE / TRANSMUCOSAL | 7360 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | DROPS / AURICULAR (OTIC) | 0.02 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FOR SUSPENSION / ORAL | 2794 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / SUBLINGUAL | 505 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| DEXTRATES | DEXTRATES | G263MI44RU | TROCHE / ORAL | 4505 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAMUSCULAR | 4 %w/v | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION / SUBCUTANEOUS | 98 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | CAPSULE, COATED PELLETS / ORAL | 10.03 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRAMUSCULAR | 4 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / OPHTHALMIC | 8 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SOFT TISSUE | 4 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | CAPSULE, DELAYED RELEASE / ORAL | 360 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, EXTENDED RELEASE / ORAL | 2575 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CREAM / VAGINAL | 586 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, DELAYED RELEASE / ORAL | 53 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | POWDER / ORAL | 63 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION / INTRAVENOUS | 900 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / TOPICAL | 0.98 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LIQUID / TOPICAL | 1 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TABLET, ORALLY DISINTEGRATING / ORAL | 15.03 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| ASPARTAME | ASPARTAME | Z0H242BBR1 | TABLET, ORALLY DISINTEGRATING / ORAL | 180 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, COATED / ORAL | 0.04 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / RECTAL | 315 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | CAPSULE, EXTENDED RELEASE / ORAL | 56 mg | ||
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| POVIDONE | POVIDONE | FZ989GH94E | TROCHE / ORAL | 30 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 8 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A077355-001 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 800MG;10MG;165MG | TABLET, CHEWABLE / ORAL | 2008-02-06 | 3bdfa0b2c4d7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 04776eec-9a0e-48a3-91f0-23f91e4b9f5e | 373e5512-0058-46dd-86e9-ce533e3f3a79 | 2019-12-18 | Warnings | 373e5512-0058-46dd-86e9-ce533e3f3a79 |
Adverse event summaries are temporarily unavailable. Other product information remains available.